Showing 2,791 results

Filters Content type: News, Editors' picks Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP

In My Case, 99% Wasn’t Enough

Editor's pick
TheBody
19 April 2023
PrEP science

As few as two PrEP pills a week protect during anal sex – but vaginal sex may need daily dosing

News
19 April 2023
PrEP policies & guidelines

US: No-Cost Preventive Services Are Now in Jeopardy. Here’s What You Need to Know.

Editor's pick
Kaiser Health News
12 April 2023
PrEP policies & guidelines

US: PrEP Advocates Convene Virtual Town Hall Responding to Braidwood v. Becerra

Editor's pick
AVAC
7 April 2023
Access to healthcare

Religious “Freedom” Laws Are Trying to Drag Us Back to the Height of the AIDS Epidemic

Editor's pick
TheBody
31 March 2023
Injectable & long-acting PrEP

Pharmaceutical corporation ViiV must provide transparency on life-saving HIV-prevention drug

Editor's pick
Médecins Sans Frontières
31 March 2023
PrEP policies & guidelines

Texas judge strikes down major Obamacare provision protecting birth control, PrEP coverage

Editor's pick
STAT
30 March 2023
Injectable & long-acting PrEP

Medicines Patent Pool signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of ViiV Healthcare’s innovative long-acting HIV prevention medicine

Editor's pick
Medicines Patent Pool
30 March 2023
Injectable & long-acting PrEP

Cabotegravir long-acting for PrEP registrations continue in Sub-Saharan Africa

Editor's pick
ViiV press release
29 March 2023
Kidney problems

Study Bite: Renal Impairment on TDF Rare With PrEP, More Common With ART

Editor's pick
TheBodyPro
29 March 2023
Experiences of stigma

Stop Feeding the PrEP-Shaming Trolls in 2023

Editor's pick
TheBody
23 March 2023
Behaviour change interventions

South West England: Increasing Uptake of PrEP in Under-served Groups

Editor's pick
Local Government Association
22 March 2023
Injectable & long-acting PrEP

Black Gay Men and Trans Women Are Well Protected by Injectable PrEP

Editor's pick
POZ
21 March 2023
PrEP programmes & uptake

Strong support systems tied to PrEP adherence among adolescent girls and young women in South Africa

News
21 March 2023
Government, leadership & policy

Hopeful HIV and Hepatitis News in Biden’s Proposed 2024 Budget

Editor's pick
POZ
20 March 2023
Injectable & long-acting HIV treatment

Top 5 stories on injectable HIV treatment and PrEP from CROI 2023

News
15 March 2023
New & experimental HIV treatments

Top 5 stories on new drugs for HIV prevention and treatment from CROI 2023

News
14 March 2023
Access to healthcare

Top 5 stories on HIV in Africa from CROI 2023

News
10 March 2023
PrEP

CROI 2023: Bone density profiles for long-acting cabotegravir vs TDF/FTC oral PrEP in young people

Editor's pick
i-Base
9 March 2023
Sexual health

Top 5 stories on sexual health from CROI 2023

News
9 March 2023
Women

Women are being failed in the fight against HIV

Editor's pick
National AIDS Trust
8 March 2023
PrEP programmes & uptake

High resilience linked to high PrEP use among Canadian men who have sex with men

Editor's pick
AJMC
6 March 2023
Young people

New study reveals parents' concerns about their sexual and gender minority teens using PrEP for HIV prevention

Editor's pick
Medical Xpress
2 March 2023
Injectable & long-acting PrEP

Experimental islatravir implants protect monkeys against HIV-like virus

News
1 March 2023